Skip to main content
. 2024 Nov 20;24:770. doi: 10.1186/s12884-024-06970-6

Table 2.

Impact of GDM on maternal outcomes in twin pregnancies (n = 1003)

maternal outcomes Non-GDM group (n = 785) GDM group (n = 218) OR (95%CI) aOR (95% CI) p-Value Adjusted
hypertensive disorders 170(21.7) 44(20.2) 0.92(0.63,1.33) 0.88(0.60,1.29) 0.515
pre-eclampsia total 114(14.5) 27(12.4) 0.83(0.53,1.30) 0.84(0.53,1.34) 0.458
< 37 weeks 100(12.7) 23(10.6) 0.81(0.50,1.31) 0.82(0.50,1.35) 0.442
< 34 weeks 20(2.5) 4(1.8) 0.72(0.24,2.11) 0.80(0.26,2.45) 0.701
preterm rupture of membranes 114(14.5) 37(17) 1.20(0.80,1.81) 1.26(0.82,1.93) 0.288
preterm delivery < 37 weeks 496(63.2) 134(61.5) 0.93(0.68,1.27) 0.97(0.70,1.33) 0.836
< 34 weeks 83(10.6) 29(13.3) 1.30(0.83,2.04) 1.38(0.85,2.24) 0.194
excessive amniotic fluid 15(1.9) 4(1.8) 0.96(0.32,2.92) 1.08(0.33,3.47) 0.902
fetal distress 58(7.4) 20(9.2) 1.27(0.74,2.16) 1.25(0.71,2.19) 0.443
fetal death 7(0.9) 1(0.5) 0.51(0.06,4.19) 0.20(0.01,3.77) 0.280
mode of delivery (Cesarean section) 766(97.6) 212(97.2) 0.88(0.35,2.22) 1.17(0.41,3.36) 0.766
postpartum hemorrhage 32(4.1) 11(5.0) 1.25(0.62,2.52) 1.22(0.59,2.53) 0.591

aOR: Adjusted odds ratio.CI: Confidence interval. AOR was corrected for age, pre-pregnancy BMI, early and middle pregnancy BMI gain, history of GDM, family history of type II diabetes, and geographic differences as covariates with P-values < 0.05 for all models